diffuse large B-cell lymphoma

Roche's Columvi win in earlier DLBCL faces questions over inconsistent patient survival data
Fierce Pharma
Sun, 06/16/24 - 08:57 pm
Roche
Columvi
diffuse large B-cell lymphoma
clinical trials
ASH: Roche offers glimpse of Columvi-Polivy combo's early lymphoma data as phase 3 kicks off
Fierce Pharma
Mon, 12/11/23 - 10:50 pm
Roche
ASH 2023
Columvi
Polivy
diffuse large B-cell lymphoma
ADC Discontinues Zynlonta Trial in DLBCL After Seven Deaths
BioSpace
Fri, 07/21/23 - 10:02 am
ADC Therapeutics
Zynlonta
diffuse large B-cell lymphoma
clinical trials
ADC Therapeutics Halts Enrollment of Zynlonta Trial After Seven Patient Deaths
BioSpace
Tue, 07/11/23 - 11:29 pm
ADC Therapeutics
Zynlonta
clinical trials
patient deaths
diffuse large B-cell lymphoma
AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race
Fierce Pharma
Sun, 05/21/23 - 07:46 pm
AbbVie
Genmab
FDA
anti-CD20
epcoritamab
diffuse large B-cell lymphoma
Epkinly
J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies
BioSpace
Tue, 05/2/23 - 11:46 am
JNJ
Janssen
Cellular Biomedicine
CAR-T
diffuse large B-cell lymphoma
FDA Green Lights Roche's Polivy in First-Line DLBCL
BioSpace
Thu, 04/20/23 - 10:45 am
Roche
Genentech
Polivy
diffuse large B-cell lymphoma
FDA
Gilead's Yescarta eyes first to move up lymphoma ladder in Europe amid busy week at EMA
Fierce Pharma
Mon, 09/19/22 - 09:12 am
Gilead Sciences
Yescarta
Europe
diffuse large B-cell lymphoma
high-grade B-cell lymphoma
Roche’s Polivy continues its regulatory dance, will head to FDA for a form of blood cancer
Endpoints
Tue, 08/16/22 - 11:17 am
Roche
Polivy
diffuse large B-cell lymphoma
FDA
Gamida doses first subject in Phase I/II cell therapy trial for lymphomas
Clinical Trials Arena
Thu, 08/11/22 - 12:17 pm
Gamida Cell
natural killer cell therapy
GDA-201
diffuse large B-cell lymphoma
follicular B-cell non-Hodgkin lymphoma
On a quest to treat newly diagnosed lymphoma patients, Roche teases positive pivotal data
Endpoints
Mon, 08/9/21 - 11:07 am
Roche
Polivy
diffuse large B-cell lymphoma
Autolus buckles down, chopping 20% of staff and seeking partner for a lead CAR-T program
Endpoints
Wed, 01/6/21 - 10:58 am
Autolus Therapeutics
ESMO
CAR-T
diffuse large B-cell lymphoma
layoffs
ASH: Gilead's CAR-T med Yescarta shows promise earlier in lymphoma therapy
Fierce Pharma
Tue, 12/8/20 - 12:07 am
Gilead Sciences
Kite Pharma
Yescarta
diffuse large B-cell lymphoma
clinical trials
FDA sets May date for verdict on ADC’s lymphoma drug Lonca
Pharmaforum
Mon, 11/23/20 - 10:20 am
ADC Therapeutics
Lonca
diffuse large B-cell lymphoma
FDA
priority review
Merck inks $2.8B VelosBio buyout to snag anti-ROR1 ADC
Fierce Biotech
Thu, 11/5/20 - 11:12 am
Merck
VelosBio
M&A
antibody-drug conjugate
diffuse large B-cell lymphoma
IPO, check: Now, ADC Therapeutics files for lonca approval
Fierce Biotech
Tue, 09/22/20 - 11:03 am
ADC Therapeutics
IPOs
FDA
loncastuximab
diffuse large B-cell lymphoma
FDA approves MorphoSys, Incyte’s drug for vulnerable lymphoma population
MedCity News
Mon, 08/3/20 - 10:14 am
FDA
Monjuvi
CAR-T
MorphoSys
Incyte
diffuse large B-cell lymphoma
One IPO attempt pulled, a drug on partial hold and a pandemic, but ADC tries again
Fierce Biotech
Wed, 04/29/20 - 10:52 am
ADC Therapeutics
IPOs
COVID-19
loncastuximab
diffuse large B-cell lymphoma
Xynomic Pharma Files For $65 Million Offering
CP Wire
Thu, 07/11/19 - 09:47 am
Xynomic Pharma
renal cell carninoma
diffuse large B-cell lymphoma
follicular lymphoma
Xynomic Pharma Files For $65 Million Offering
Thu, 07/11/19 - 09:44 am
Xynomic Pharma
renal cell carninoma
diffuse large B-cell lymphoma
follicular lymphoma

Pages